The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine.
about
Changing the Protease Specificity for Activation of a Flavivirus, Tick-Borne Encephalitis VirusAvian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetAttenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.Continuous cell lines as a production system for influenza vaccines.Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984.Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine.Vaccine development for protecting swine against influenza virus.Protease activation mutants elicit protective immunity against highly pathogenic avian influenza viruses of subtype H7 in chickens and mice.Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs.Principles underlying rational design of live attenuated influenza vaccines.Influenza virus pathogenicity is determined by caspase cleavage motifs located in the viral proteins.Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase.
P2860
Q27486787-0ACF4066-9653-4E84-96DC-A2AD91114B79Q30227194-0F644474-65F6-411F-8B83-3F1324E1E33BQ30371054-2BE3B9B6-E600-4686-995C-A1928047190EQ30382947-D5D836E5-4C98-4FDA-99D9-B90FB8DC4D08Q30385956-B94AFE13-675A-48FD-A773-55276807C7A0Q30420569-BC5FB346-C59F-4AC2-A4B3-53AE28E1A1C3Q30424943-C6871952-8412-4DFA-AAD0-8E7AB4B7C80FQ36778856-C0643151-F09B-41B1-9873-6045A7B79D6EQ37356103-1285D0E1-9992-44BB-884D-D51B18050CBCQ39770895-EFB9E4C2-0E5A-45B8-8FD5-2E487A76FF2EQ41841585-2F95F39B-7213-422B-A443-C6CD30A5F373Q41898855-462DF7E3-2608-4DC7-9802-7EDBD37AF2B5Q42373505-3AFDB597-1E0D-4F9A-B087-92D4D3B9DA2D
P2860
The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The potential of a protease ac ...... s for a pandemic live vaccine.
@ast
The potential of a protease ac ...... s for a pandemic live vaccine.
@en
type
label
The potential of a protease ac ...... s for a pandemic live vaccine.
@ast
The potential of a protease ac ...... s for a pandemic live vaccine.
@en
prefLabel
The potential of a protease ac ...... s for a pandemic live vaccine.
@ast
The potential of a protease ac ...... s for a pandemic live vaccine.
@en
P2093
P1433
P1476
The potential of a protease ac ...... us for a pandemic live vaccine
@en
P2093
P304
P356
10.1016/J.VACCINE.2007.11.052
P407
P50
P577
2007-12-10T00:00:00Z